Hepatitis A, B, and C Prevention Programs
Information and Programs for Adults and Adolescents at Risk
 
  Home
  Hep Express archives
    Search
 

Prevention Programs

  APIA programs
  Corrections, adult
  Corrections, juvenile
  Family planning
  Harm reduction
  Homeless programs
  MSM
  Perinatal related
  School programs
  STD/HIV
  Other programs
  Index of programs
    Support Group Info
  Hepatitis B
  Hepatitis C
  Listed by state
    Hepatitis B Info
  FAQ about hep B
  VISs
  Laws and mandates
  Case histories
  Photos
  Videos
    Hepatitis A Info
  FAQ about hep A
  VISs
  Laws and mandates
  Case histories
  Photos
    Hep-related Topics
  International adoption
  Tattooing and piercing
  Travel vaccination
  Healthcare workers
  Needle safety
  Dialysis
    Other Information
  CDC website
  Hep organizations
  NASTAD website
  Contact NASTAD
  About NASTAD
  Privacy policy
 

(click on the image)




Perinatal Related
Programs for Asian Pacific Islanders

 
Perinatal and Asian Pacific Islander (API) Hepatitis B Program
Program name: Perinatal and Asian Pacific Islander (API) Hepatitis B Program
Population served: Clients who are at risk of transmitting hepatitis B virus perinatally and the API
Eligibility: Client must be eligible for vaccines for children program (VFC)
Region served: Washington State
Funding: VFC
Program started: 1990
Number of clients:  
Contact: Shana Johnny
111 Israel SE
Olympia, WA. 98504-7843
Phone: 360-236-3698
Fax: 360-236-3590
Email: shana.johnny@doh.wa.gov
Website: None
Description:

Prevention of Perinatal Hepatitis B

In 1990, Washington State established a program to prevent perinatal HBV infections. Department of Health staff collaborate with Perinatal Hepatitis B Coordinators designed in each local health jurisdiction to assure case management services are provided. The key elements of perinatal HBV prevention include:

  1. HBsAg screening of all pregnant women,
  2. Identification and reporting of HBsAg-positive pregnant women and assurance that infants receive HBIG and hepatitis B vaccine dose 1 at birth, and the three dose series by 6-8 months, Postvaccination testing of infants to assess infectivity and immune status, and and identification, screening, and vaccination of household/sexual contacts is also done. Annual assessments are competed to assure that program objectives are reached. Approximately 60% of the expected births to HBsAg-positive women are identified per year. Additional efforts can be done to identify more women in order to assure follow-up services are provided to infants and household contacts.

To make certain that infants born to HBsAg-positive mothers receive prompt and appropriate preventive treatment, each pregnancy for an HBsAg-positive woman is a notifiable condition (Reporting requirement: Washington Administrative Code (WAC) 246-101-101) The coordinator of the Perinatal Hepatitis B Prevention Program (PHBPP) for each local health jurisdiction handles the reports and the reports are then sent to the state perinatal hepatitis B surveillance system .

Additionally, The Perinatal Hepatitis B Program and Communicable Disease Epidemiology Section collaborate to assure that information about each perinatal hepatitis B case is received by CDC’s Perinatal Program as well as by the surveillance epidemiologists in CDC’s Division of Viral Hepatitis.

DOH Communicable Disease Epidemiology-877-539-4344 or 206-418-5500 DOH Immunization Program CHILD Profile-360-236-3595.


Nastad
www.nastad.org
nastad@nastad.org
          Hepatitis Prevention Programs
www.hepprograms.org
nastad@nastad.org

444 North Capitol Street, NW • Suite 339 • Washington D.C. 20001 • (202) 434-8090